CAH Stock: Price, Earnings History and SEC Filings
Cardinal Health, Inc. (CAH) last traded at $250.48, down 0.24% on the latest session and up 12.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.91 against an analyst estimate of $2.42, a beat of 20.2%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CAH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $2.91 | $2.42 | +20.25% |
| Mar 2026 | Apr 30, 2026 | $3.17 | $2.80 | +13.21% |
| Dec 2025 | Feb 5, 2026 | $2.63 | $2.39 | +10.04% |
| Sep 2025 | Oct 30, 2025 | $2.55 | $2.21 | +15.38% |
CAH beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How CAH reacts to earnings
Across its last 8 earnings releases, CAH moved 6.1% on average the next session, in either direction. It rose after 6 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-11 | Before open | +1.30% |
| 2026-04-30 | Before open | -4.90% |
| 2026-02-05 | Before open | +9.83% |
| 2025-10-30 | Before open | +15.43% |
| 2025-08-12 | Before open | -7.21% |
| 2025-05-01 | Before open | +3.00% |
| 2025-01-30 | Before open | +0.39% |
| 2024-11-01 | Before open | +7.01% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
CAH financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $254.2B | $1.7B | $4.5B | 0.7% | $7.23 |
| 2025 | $222.6B | $1.6B | $1.9B | 0.7% | $6.45 |
| 2024 | $226.8B | $852M | $3.3B | 0.4% | $3.45 |
| 2023 | $205.0B | $330M | $2.4B | 0.2% | $1.26 |
| 2022 | $181.3B | -$938M | $2.8B | -0.5% | $-3.37 |
| 2021 | $162.5B | $611M | $2.0B | 0.4% | $2.08 |
| 2020 | $152.9B | -$3.7B | $1.6B | -2.4% | $-12.61 |
| 2019 | $145.5B | $1.4B | $2.4B | 0.9% | $4.53 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CAH
- 8-K · Oct 1, 2026Regulation FD disclosure, Financial statements and exhibits
- DEF 14A · Sep 21, 2026
- 10-K · Aug 11, 2026
- 8-K · Aug 11, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 11, 2026Material agreement, Agreement terminated, New financial obligation
- 8-K · Aug 5, 2026Officer or director change
- 10-Q · Apr 30, 2026
- 8-K · Apr 30, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Mar 23, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Mar 5, 2026Officer or director change
Insider filing activity
CAH insiders filed 23 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
CAH news
- Is Buying McKesson Stock Near Its High A Bad Idea?Oct 30, 2026 · trefis.com
- Is It A Mistake To Buy Cardinal Health Stock At A High?Oct 29, 2026 · trefis.com
- West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top EstimatesOct 29, 2026 · finance.yahoo.com
- Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You TradeOct 27, 2026 · finance.yahoo.com
- Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings ResultsOct 27, 2026 · finance.yahoo.com
- Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?Oct 27, 2026 · fool.com
- Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?Oct 24, 2026 · fool.com
- Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?Oct 22, 2026 · fool.com
About Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) is a US-listed public company on NYSE. The SEC classifies its business as Wholesale-drugs Proprietaries & Druggists' Sundries. It is incorporated in OH. Its fiscal year ends in June.